Health Care & Life Sciences » Biotechnology | PhoenixBio Co. Ltd.

PhoenixBio Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2015
2016
2017
2018
2019
Net Income before Extraordinaries
62,607.00
147,121.00
130,352.00
267,336.00
295,150
Depreciation, Depletion & Amortization
21,530.00
22,199.00
25,016.00
24,432.00
63,035
Other Funds
-
-
1,440.00
3,456.00
18,578
Funds from Operations
60,779.00
190,206.00
154,754.00
221,489.00
213,534
Changes in Working Capital
68,655.00
69,203.00
109,926.00
34,292.00
54,000
Net Operating Cash Flow
7,876.00
259,409.00
44,828.00
187,197.00
159,534
Capital Expenditures
7,768.00
19,720.00
9,580.00
6,373.00
Sale of Fixed Assets & Businesses
13,716.00
-
-
-
Purchase/Sale of Investments
-
113,620.00
108,410.00
-
Net Investing Cash Flow
6,273.00
136,861.00
98,829.00
451,611.00
Issuance/Reduction of Debt, Net
53,264.00
54,529.00
21,727.00
59,539.00
Net Financing Cash Flow
46,235.00
734,708.00
20,286.00
62,995.00
Net Change in Cash
54,559.00
823,110.00
144,244.00
702,366.00
Free Cash Flow
15,644.00
241,457.00
35,248.00
191,734.00
Net Assets from Acquisitions
-
-
-
444,363.00
Other Sources
325.00
-
-
-
Change in Capital Stock
99,499.00
789,237.00
-
-
Exchange Rate Effect
9,927.00
34,146.00
19,699.00
563.00
Other Uses
-
3,520.00
-
875.00

About PhoenixBio Co.

View Profile
Address
3-4-1 Kagamiyama
Higashi-Hiroshima Hiroshima 739
Japan
Employees -
Website http://www.phoenixbio.co.jp
Updated 07/08/2019
PhoenixBio Co., Ltd. operates as a holding company that develops technologies for mass propagation of human cells into laboratory animals. Its solutions encompass PXB mouse services, Tg & KO animal services, and hair regeneration projects. The firm also offers its technologies to researchers by conducting in-house study services with custom produced transgenic animals.